TransMedics Group, Inc.
(NASDAQ: TMDX)

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

138.630

-1.470 (-1.05%)
Range 133.500 - 139.750   (4.68%)
Open 139.620
Previous Close 140.100
Bid Price 69.670
Bid Volume 10
Ask Price 69.800
Ask Volume 14
Volume 644,550
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis